60.07
5.61%
3.19
Vorhandelsmarkt:
59.96
-0.11
-0.18%
Schlusskurs vom Vortag:
$56.88
Offen:
$57.06
24-Stunden-Volumen:
1.25M
Relative Volume:
0.86
Marktkapitalisierung:
$9.11B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
28.88
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
-1.94%
1M Leistung:
+5.39%
6M Leistung:
-2.94%
1J Leistung:
-16.50%
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
60.07 | 9.11B | 3.24B | 304.90M | 156.70M | 2.08 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-19 | Eingeleitet | Guggenheim | Buy |
2024-12-10 | Eingeleitet | UBS | Neutral |
2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
2024-10-15 | Eingeleitet | Barclays | Overweight |
2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-06-03 | Fortgesetzt | Jefferies | Buy |
2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2022-10-21 | Eingeleitet | UBS | Buy |
2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
2021-10-15 | Fortgesetzt | Cowen | Market Perform |
2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | Eingeleitet | Goldman | Sell |
2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
2019-06-24 | Bestätigt | Needham | Strong Buy |
2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
2019-05-06 | Bestätigt | Needham | Strong Buy |
2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | Hochstufung | UBS | Sell → Neutral |
2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
2019-02-12 | Bestätigt | BTIG Research | Buy |
2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corp (BRKR) Stock Price Up 5.01% on Jan 21 - GuruFocus.com
Bruker (NASDAQ:BRKR) Stock Price Down 5.3%Here's What Happened - MarketBeat
Guggenheim Reiterates "Buy" Rating for Bruker (NASDAQ:BRKR) - MarketBeat
S&P 500 Futures Climb in Premarket Trading; JB Hunt Transport, Bruker Corp Lag - Barron's
Bruker Corp appoints new Chief Accounting Officer - MSN
Bruker (NASDAQ:BRKR) Shares Down 5.3%Should You Sell? - MarketBeat
BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope - MSN
Citi maintains Bruker shares outlook, notes attractive setup heading into 2025 - Investing.com Canada
BofA reaffirms Bruker shares outlook, highlights execution in challenging environment By Investing.com - Investing.com South Africa
Bruker Shares Limited Information Under SEC Regulations - TipRanks
BofA reaffirms Bruker shares outlook, highlights execution in challenging environment - Investing.com
Jane Street Group LLC Sells 161,019 Shares of Bruker Co. (NASDAQ:BRKR) - MarketBeat
Chromatography System Market to Reach US$ 2.62 Billion with 6.6% CAGR by 2034 | Fact.MR Report - GlobeNewswire Inc.
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research – Company Announcement - Financial Times
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research - Yahoo Finance
Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Earnings Review and Free Research Report: Bruker’s Adjusted Diluted EPS Increased 15% - AccessWire
Bruker Co. (NASDAQ:BRKR) Holdings Reduced by Franklin Resources Inc. - MarketBeat
Bruker Misses Where it Counts - AOL
Is Bruker Corporation (BRKR) Among the Best Nanotechnology Stocks to Buy According to Hedge Funds? - Insider Monkey
Bruker seeks to pause injunction of GeoMx in the US after court ruling - Yahoo Finance
Investors in Bruker (NASDAQ:BRKR) have unfortunately lost 27% over the last three years - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Bruker plans to file for a stay of NanoString GeoMX injunction ruling - MSN
Bruker ‘respectfully disagrees’ with District Court, to seek stay of injunction - Yahoo Finance
Bruker plans to file for a stay of NanoString GeoMX injunction ruling (NASDAQ:BRKR) - Seeking Alpha
Bruker to appeal patent infringement ruling - Investing.com
Bruker Comments on Delaware District Court’s Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products - Yahoo Finance UK
10x Genomics secures injunction against Bruker By Investing.com - Investing.com South Africa
10x Genomics secures injunction against Bruker - Investing.com
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products - Quantisnow
Bruker Adds Another 1.2 GHz NMR System In Switzerland, Stock Climbs - Barchart
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Shares Bought by Barclays PLC - MarketBeat
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products – Company AnnouncementFT.com - Financial Times
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility - newsbreak.com
Bruker stock supported by Guggenheim for undervalued position amid life sciences tools advancements - Investing.com
Bruker (NASDAQ:BRKR) Coverage Initiated at Guggenheim - MarketBeat
Guggenheim Initiates Coverage of Bruker (BRKR) with Buy Recommendation - MSN
Geode Capital Management LLC Increases Stock Position in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker (NASDAQ:BRKR) Price Target Raised to $80.00 - MarketBeat
State Street Corp Has $250.50 Million Holdings in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
Bruker gets neutral shares rating, price target set on sales growth - Investing.com
Janus Henderson Group PLC Purchases 21,793 Shares of Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker stock upgraded as high growth focus offsets pharma capex recovery risks - Investing.com
This ConocoPhillips Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
This Bruker Insider Increased Their Holding In The Last Year - Yahoo Finance
Bruker director Richard Packer sells $193,682 in stock By Investing.com - Investing.com Australia
Bruker director Richard Packer sells $193,682 in stock - Investing.com
Bruker Stock Might Rise From the Launch of Dimension Nexus AFM - MSN
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):